CH
EFTR

CVI Holdings’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

CVI Holdings’s Portfolio EFTR Stock Details EFTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,000
Closed -$1.98M – 932
2021
Q2 		$1.98M Hold
8,000
– – 0.13% 230
2021
Q1 		$1.92M Buy
+8,000
New +$1.96M 0.13% 243

Other funds holding EFTR

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CVI Holdings's EFTR Position: Q3 2021 in Review

CVI Holdings sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q3 2021, closing a stake of 8,000 shares — an estimated $1.98M sold.

CVI Holdings first reported a position in EFTR in Q1 2021 and held it in 2 quarters. The position peaked at $1.98M in Q2 2021. 12 funds tracked by Wall St. Rank hold EFTR as of Q3 2021.

  • CVI Holdings reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • CVI Holdings sold 8,000 eFFECTOR Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $1.98M.
  • CVI Holdings first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • CVI Holdings's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $1.98M in Q2 2021.
  • 12 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2021.

Based on CVI Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.